ChemicalBook > Product Catalog >API >Blood System Drugs >Anticoagulant and Antiplatelet Drugs >Argatroban

Argatroban

Argatroban Structure
CAS No.
74863-84-6
Chemical Name:
Argatroban
Synonyms
Argatraban;(2R,4R)-4-Methyl-1-[N-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl]-2-piperidinecarboxylic acid;MQP;MQPA;MD-805;ARG025;OM 805;DK-7419;Slonnon;MCI-9038
CBNumber:
CB7738830
Molecular Formula:
C23H36N6O5S
Molecular Weight:
508.63
MOL File:
74863-84-6.mol
Modify Date:
2023/6/30 15:45:59

Argatroban Properties

Melting point 188-1890C
Boiling point 777.2±70.0 °C(Predicted)
Density 1.47±0.1 g/cm3(Predicted)
storage temp. Keep in dark place,Sealed in dry,2-8°C
solubility Soluble in DMSO (up to 50 mg/ml).
pka 10.44±0.40(Predicted)
form White to off-white powder.
color White
Stability Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 1 month.
InChIKey KXNPVXPOPUZYGB-IOVMHBDKSA-N
SMILES N1(C(=O)[C@@H](NS(C2C3=C(C=CC=2)CC(C)CN3)(=O)=O)CCCNC(N)=N)CC[C@@H](C)C[C@@H]1C(O)=O
CAS DataBase Reference 74863-84-6(CAS DataBase Reference)

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS06
Signal word  Danger
Hazard statements  H301-H311-H331
Precautionary statements  P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501
NFPA 704
0
3 0

Argatroban Chemical Properties,Uses,Production

Description

Argatroban is a new synthetic antithrombotic agent useful in maintenance anticoagulation them ischemic stroke and disseminated intravascular coagulation. In patients on hemodialysis, argatroban is su enor to heparin, generating a more stable antithrombin effect. Other potential uses include progressing ischemic stroke and disseminated intravascular coagulation.

Chemical Properties

White to Off-White Crystalline Solid

Pharmacokinetics

Argatroban is administered subcutaneously because of the low lipophilicity of the drug. The drug is bound to plasma protein and is metabolized via CYP3A4/5 to the aromatized metabolite and the two hydroxylated metabolites. The M-1 metabolite retains 20 to 30% of the antithrombotic activity. Coadministration of argatroban with inhibitors of CYP3A4 does not appear to produce clinically significant effects. Argatroban is eliminated via biliary secretion into the feces.

Clinical Use

Argatroban has been approved for the prophylaxis and treatment of thrombosis in patients with HIT (79). Argatroban is a peptidomimetic that binds selectively to the catalytic site of thrombin as a univalent competitive DTI. Argatroban is available as a mixture of 21-R and 21-S diastereomers (64:36), with the S-isomer approximately twice as potent as the R-isomer. The drug is a reversible inhibitor of both free thrombin as well as clot-bound thrombin.

Global( 290)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Anant Pharmaceuticals Pvt Ltd +91-8550986868 +91-9485998001 Haryana, India 461 58 Inquiry
Global Calcium Pvt Ltd +91-8050750904 +91-8040554500 Karnataka, India 132 58 Inquiry
Clearsynth Labs 91-22-45045900 Maharashtra, India 3889 58 Inquiry
Manus Aktteva Biopharma LLP 08048250218Ext 800 Ahmedabad, India 655 58 Inquiry
Pharma Affiliates 172-5066494 Haryana, India 6761 58 Inquiry
Apan Imex Private Limited 91-79-26850087 Gujarat, India 31 58 Inquiry
Athos Chemicals 91-9998858909 Gujarat, India 315 58 Inquiry
Manus Aktteva +91 (79) 6512-3395 New Delhi, India 581 34 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry

Argatroban Spectrum

Argipidine MQP ARG025 MQPA Argatroban (2R,4R)-1-[5-[(Aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid (2R)-1-[Nα-(3-Methyl-1,2,3,4-tetrahydroquinoline-8-ylsulfonyl)-L-arginyl]-4α-methylpiperidine-2β-carboxylic acid (2R,4R)-1-[(2S)-5-Guanidino-2-(1,2,3,4-tetrahydro-3-methylquinolin-8-ylsulfonylamino)valeryl]-4-methylpiperidine-2-carboxylic acid MD-805 DK-7419 MCI-9038 MD-805:OM-805:Novastan:Slonnon (2R,4R)-1-((2S)-5-Guanidino-2-(3-Methyl-1,2,3,4-tetrahydroquinoline-8-sulfonaMido)pentanoyl)-4-Methylpiperidine-2-carboxylic acid Novastan OM 805 Slonnon 2-Piperidinecarboxylicacid,1-[(2S)-5-[(aMinoiMinoMethyl)aMino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-Methyl-8-quinolinyl)sulfonyl]aMino]pentyl]-4-Methyl-,(2R,4R)- Argatroban Argatroban (Mixture of Diastereomers) Argatroban(mixture of isomers) (2R,4R)-1-[(2S)-5-[(Aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]- Ar atroban (2R,4R)-1-((S)-5-Guanidino-2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonamido)pentanoyl)-4-methylpiperidine-2-carboxylic acid (2S,4S)-1-(2R)-Argatroban (2R,4R)-1-(2S)-Argatroban Argatroban USP/EP/BP Argatroban (10mM in DMSO) Argatroban (MD805 TIANFU-CHEM CAS:74863-84-6 Argatroban Argatraban (2R,4R)-4-Methyl-1-[N-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl]-2-piperidinecarboxylic acid Agatroban Argatroban (MCI-9038) 74863-84-6 C23H36N6O5S Amines Chiral Reagents Heterocycles Sulfur & Selenium Compounds Intermediates & Fine Chemicals Pharmaceuticals 74863-84-6